The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
Zidavi is recommended by the Infectious Disease Society of America
Subject Expert Committee(SEC) of Central Drugs Standard Control Organization (CDSCO)
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
Younger Indians have a 10 times higher rate of heart attack
Brings 25 years of global operations and supply chain experience to Piramal
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
Subscribe To Our Newsletter & Stay Updated
